Today: 8 February 2026
Subscribe
Browse Category

Stock Market News 3 October 2025 - 4 October 2025

Mercurity Fintech (MFH) Stock Explodes Amid Crypto & AI Bets – 1,000% Rally or Bubble?

Up 1,400% in a Year: Is Mercurity Fintech (MFH) the Next Crypto-Fintech Breakout or a Bubble?

MFH’s 2025 Surge: Stock and Financial Performance Mercurity Fintech Holding’s stock has been on a tear in 2025, cementing its status as one of the year’s top micro-cap performers. After starting the year in the single digits (adjusted for splits), MFH shares recently hit $29.41 (as of early October 2025) stockanalysis.com. Year-to-date the stock has climbed over 330% (vs ~14% for the S&P 500) and is up roughly 1,400% from a year ago finance.yahoo.com. This explosive rally accelerated in the second half of 2025, coinciding with a crypto market boom and a flurry of corporate developments (detailed below). The stock’s
4 October 2025
····
Ondas Holdings Skyrockets into the U.S. Defense Drone Race – Is ONDS the Next Tech Titan?

Ondas Holdings: Is This Drone‑Defense Upstart the Next Big Thing or a Bubble About to Burst?

Company Overview Ondas Holdings owns two synergistic businesses: Founded in 2014, the company is headquartered in Massachusetts and employs around 124 people stockanalysis.com. Management promotes a “data‑as‑a‑service” model in which drones collect and process information autonomously, allowing customers to subscribe rather than own hardware. Recent Stock Performance (2025) The 2025 run in ONDS has been nothing short of spectacular. Year‑to‑date performance exceeds 290 % tradingview.com, driven by a flood of defense‑related announcements and retail enthusiasm. Shares traded below $1 at the start of 2024 and now hover near $10—an eleven‑fold increase within a year tradingview.com. Part of this surge came on
4 October 2025
···
Cidara Therapeutics (CDTX) Surges on Accelerated Flu Drug Trial – Key Updates for Investors

Cidara Therapeutics (NASDAQ: CDTX) 2025 Investment Analysis – Will This Anti‑Flu Innovator Keep Soaring?

2025 Year‑to‑Date Stock Performance Cidara’s stock has been among the best performers in biotech. According to YTDReturn.com, a US$10,000 investment on 31 Dec 2024 would have grown to ~US$37,943 by 3 Oct 2025 because the share price increased from US$26.88 to US$101.99, a 279.43 % YTD return ytdreturn.com. Zacks similarly reported a 217.8 % YTD rally by late September nasdaq.com, reflecting further gains in October. The stock traded between US$10.14 and US$106.63 over the past year stockanalysis.com and surged 695.5 % year‑on‑year nasdaq.com. The rally was driven by positive trial data, accelerated regulatory milestones and speculative interest. Cidara’s Cloudbreak platform generated excitement because the CD388 candidate could
4 October 2025
·
Super Micro Computer (SUPX) 2025: Can the AI‑Server Pure‑Play Keep Its Edge?

Super Micro Computer (SUPX) 2025: Can the AI‑Server Pure‑Play Keep Its Edge?

Review of SUPX Performance in 2025 Financial results Super Micro Computer’s fiscal‑2025 (year ended June 30 2025) marked another year of explosive growth but also revealed some strains. Net sales for the full year jumped to $22 billion—almost triple revenue in FY‑2023. Fourth‑quarter revenue came in at $5.8 billion, missing analysts’ $5.88 billion estimate and reflecting slower hyperscale demand. Quarterly net income dropped to $195 million and diluted EPS $0.31, while full‑year net income reached $1.0 billion and EPS $1.68 ir.supermicro.com. The company’s gross margin narrowed to 9.5 % (from 10.2 % a year earlier) amid tariff‑related costs and price competition morningstar.com. Cash flow from operations totaled $864 million in Q4,
4 October 2025
·
Quantum Computing Inc. (QUBT): 2025’s Wild 3,200% Quantum Stock Surge – Boom or Bubble?

Quantum Computing Inc. (QUBT): 2025’s Wild 3,200% Quantum Stock Surge – Boom or Bubble?

Stock Performance & Volatility in 2025 QUBT’s share price has been on a rollercoaster in 2025, reflecting both speculative hype and sudden reversals. After an explosive rally in late 2024 (the stock jumped +530% in Nov 2024 and another +134% in Dec 2024 Portfolioslab), QUBT entered 2025 at lofty levels and promptly cratered: shares plunged about –37% in January 2025 and –42% in February 2025 Portfolioslab, wiping out roughly two-thirds of its value in the first two months. This steep pullback from the late-2024 peak was likely a combination of profit-taking and sober reflection on the minimal fundamentals supporting the
4 October 2025
····
Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Quantum Rocket or Bubble? RGTI’s Stunning Surge Explained—And How It Stacks Up to IonQ, D‑Wave, and QUBT

Key facts (as of Oct 4, 2025) CEO Subodh Kulkarni: “Our industry‑leading chiplet approach to scaling and strong financial position makes us confident in hitting our end‑of‑year technology goals.” GlobeNewswire What Rigetti does—at a glance Rigetti is a full‑stack, superconducting, gate‑based quantum‑computing company. It manufactures chips in‑house (Fab‑1), exposes systems via its cloud and major clouds (AWS/Azure), and now sells on‑prem systems (Novera) to labs and corporates. Recent news shows early commercial demand (on‑prem orders) and government validation (AFRL)—key steps in moving from pure R&D to monetization. Amazon Web Services, Inc.+2GlobeNewswire+2 2025 performance drivers: why the stock exploded Financials &
4 October 2025
··
Regencell (RGC) Stock Skyrockets 64,000% – Miracle Biotech or Bubble?

Regencell (RGC) Stock Skyrockets 64,000% – Miracle Biotech or Bubble?

RGC’s 2025 Rollercoaster: From Penny Stock to $33B Phenomenon Regencell Bioscience’s journey in 2025 has been nothing short of astonishing. The company went from an obscure penny stock (literally trading under 10 cents) to a meteoric high of $83.60 within months Stockanalysis. This 820-fold increase was “far stranger” than a typical biotech breakthrough – it happened without any major scientific news or product launch Gurufocus. Instead, a perfect storm of speculative forces sent RGC into the stratosphere. The catalyst was announced in early June: a 38-for-1 stock split. Overnight, Regencell’s share count multiplied and the price per share dropped from
4 October 2025
·
Huawei Mate X5 Ultimate 5G Shakes Up the Foldable Phone Wars

Huawei Mate X5 Ultimate 5G Shakes Up the Foldable Phone Wars

Huawei Mate X5 Ultimate 5G – Overview and Specs Huawei’s Mate X5 Ultimate 5G is a statement of the company’s resilience and innovation in the foldable arena. It closely resembles its predecessor (the Mate X3) in design androidheadlines.com, but skips the “X4” naming. Instead, Huawei jumped to X5 – a deliberate omission since the number 4 is considered bad luck in China androidheadlines.com. The Mate X5 sports an inward-folding design with two high-quality OLED screens: a flexible 7.85″ inner display (2496×2224 resolution, ~426 ppi) and a 6.4″ outer cover display (2504×1080) androidheadlines.com androidheadlines.com. Both panels support a smooth 120Hz refresh
4 October 2025
··
Bitdeer Stock Soars on Crypto Boom – Nears $20 as Bitcoin Hits New Highs

Bitdeer Stock Soars on Crypto Boom – Nears $20 as Bitcoin Hits New Highs

Summary: On Oct 3, 2025, Bitdeer Technologies (NASDAQ: BTDR) closed at $19.42, up +10.28% for the day investing.com. This rally comes amid a broader crypto surge – Bitcoin is trading near all-time highs (~$124K) after a week-long, ~12–15% rally economictimes.indiatimes.com coindesk.com. Bitdeer’s recent positive news (new mining rigs, higher production and revenue) plus bullish analyst calls have helped fuel the stock’s jump. Analysts now have an average 12‑month price target around $22–25 (range $17–42) marketbeat.com nasdaq.com, implying significant upside. Peers Marathon Digital (MARA), Riot Platforms (RIOT) and Hut 8 (HUT) have also seen big moves on the crypto upswing coindesk.com
3 October 2025
··
Tarsus Eyedrop Breakthrough Sends Stock Soaring: 10.9% Rally and Counting

Tarsus Eyedrop Breakthrough Sends Stock Soaring: 10.9% Rally and Counting

Company Overview and Recent Developments Tarsus Pharmaceuticals (NASDAQ: TARS) is a biopharma focused on eye care. Its flagship product XDEMVY (lotilaner ophthalmic solution) was FDA-approved in July 2023 as the first-ever treatment for Demodex blepharitis (eyelid inflammation caused by Demodex mites) globenewswire.com. Tarsus reports that XDEMVY’s launch has exceeded expectations – CEO Bobak Azamian called the Q2 results their “strongest quarter to date” and emphasized XDEMVY as the new standard of care nasdaq.com. Management notes more than 20,000 eye doctors are now prescribing XDEMVY (a >30% rise since early 2025) nasdaq.com, backed by national TV advertising (e.g. Golden Globes and NFL playoff spots
3 October 2025
··
Humana (HUM) Stock Skyrockets on Medicare News – What Investors Must Know Today

Humana Stock Skyrockets as Medicare Advantage News Ignites Rally

Stock Performance and Recent Moves On Oct. 3, 2025 Humana’s stock surged sharply – closing up ~10.6% after a late afternoon rally stockstory.org. Intraday gains peaked around +11.9% as news broke that Humana’s Medicare Advantage star ratings and plan enhancements were better than feared. (By comparison, the prior day Humana had already jumped ~6% on Oct. 2 when preliminary MA star ratings were disclosed stockstotrade.com.) The Oct. 3 close near $283.72 was well above the ~$256 level of just days earlier, reflecting strong investor enthusiasm. Trading volume was heavy, and market commentary noted that moves of this size are rare
3 October 2025
White Mountains Stock Skyrockets on $1.75B Bamboo Deal and Major CEO Shake-Up

White Mountains Stock Rockets +10% on $1.75B Bamboo Deal – What Investors Need to Know

Figure: White Mountains’ share price spiked on Oct. 3, 2025 after announcing the $1.75B Bamboo sale reuters.com investing.com. Stock Surge on Oct. 3, 2025 White Mountains saw one of its biggest single-day moves in years on Oct. 3, 2025. After closing the prior day near $1,665, WTM stock jumped nearly 11% intraday reuters.com, settling around $1,841 by market close (a gain of +10.62% from the previous close). This surge was driven by the surprise announcement that morning: WTM signed an agreement to sell most of its Bamboo homeowners insurance business to private equity firm CVC reuters.com investing.com. Investors reacted strongly because Bamboo had been
3 October 2025
·
QuantumScape (QS) Stock Skyrockets 14% on Solid-State EV Battery Breakthrough – Can the Rally Continue?

QuantumScape Rockets 11% to $15.92 on Solid-State Battery Breakthroughs

Stock Performance and Recent Moves QuantumScape shares have soared in recent days, reflecting renewed investor optimism in its solid-state battery roadmap. On Oct. 1 (Wednesday) after markets closed, QS jumped 18.43% to a $14.59 close investing.com, driven by news of the Corning partnership (announced Sept. 30). The rally continued into the week’s end: by market close Oct. 3 (Friday), QS hit $15.92 (+11.33%), setting a fresh 52-week high. (Intraday high was about $16.49 investing.com.) Benzinga noted the stock’s “impressive climb” on Oct. 3, with volume well above average and a breakout past resistance near $14.70 benzinga.com benzinga.com. Year-to-date, QS is up roughly +150–200%, far outperforming the
3 October 2025
·
Rigetti Computing’s Quantum Leap: Stock Soars on Breakthroughs and Bold Bets

Rigetti (RGTI) Quantum Stock Rockets on Big Deals – Is the $10B Hype Real?

Key Facts: Rigetti’s stock is near record highs (~$35–39 as of Oct 3, 2025 nasdaq.com), giving it a market capitalization around $11.5 billion public.com (up ~2,500% over 12 months public.com). 2025 has seen an enormous rally (RGTI is up ~127% YTD tipranks.com), fueled by major contracts. In late September 2025 Rigetti announced $5.7M in new Novera quantum computer orders datacenterdynamics.com insidermonkey.com and a $5.8M U.S. Air Force quantum networking deal rigetti.com. By Q2 2025 Rigetti’s revenues were still very small (~$1.8M in Q2) and losses large (net loss $39.7M globenewswire.com), but it raised ~$385M in equity (including a $350M ATM)
3 October 2025
··
Quantum Leap: D-Wave (QBTS) Stock Skyrockets 2000% Amid Fed Rate Cuts and AI-Fueled Quantum Breakthroughs

Quantum Computing Frenzy: D-Wave (QBTS) Stock Surges 289% in 2025 on Breakthrough Deals

Stock Performance & Technical Trends D-Wave’s stock has undergone a parabolic rally in recent months. After trading in the low-mid $15s in early September 2025, QBTS broke sharply higher around Sept 16–17, climbing above key resistance and trading range highs investopedia.com stockanalysis.com. It rapidly hit a new 52-week and all-time high (~$33) by Oct 3 (intra-day high $33.16) stockanalysis.com. Technical observers note this move came on record volumes and in tandem with bullish signals: the breakout above the prior range came as RSI moved into overbought territory, but with room before prior peaks investopedia.com. Indeed, volume on Oct 3 (~77M
3 October 2025
···
Oscar Health (OSCR) Stock Surges on Expansion Plans – What Analysts Are Saying

Oscar Health (OSCR) Stock Skyrockets – Major News & Analyst Insights (Oct 2025)

Key Facts: Oscar Health’s stock recently jumped to roughly $21.5 on Oct 3, 2025 (up ≈11% that day) indmoney.com. Over the past week, the stock is up about 8% marketscreener.com. In Q2 2025, Oscar reported $2.9 billion revenue (+28–30% YoY) but a $228 million net loss ($0.89/share) due to a high medical loss ratio tradingview.com. Management has reaffirmed full-year 2025 guidance (revenues ~$11.2–11.3 B, operating income $225–275 M) at the Wells Fargo conference ainvest.com ainvest.com, and in July raised its revenue outlook to ~$12.0–12.2 B (but warned medical costs would be higher, with MLR ~86–87%) investing.com. Analysts are broadly bearish: MarketBeat shows a consensus “Strong
3 October 2025
Archer Aviation Skyrockets: eVTOL Test Milestones & Stock Surge Ignite Industry Buzz

Archer Aviation Skyrockets: eVTOL Test Milestones & Stock Surge Ignite Industry Buzz

Stock Performance & Market Reaction Over the past month, ACHR has rebounded from sub-$9 levels to the low-$11s on mixed news. After a late-September rally, Archer opened Oct 2025 at about $9.95 and spiked to $11.52 on Oct 3 stockanalysis.com, buoyed by test-flight achievements and funding news. Trading volume has surged (e.g. 93 million shares on Oct 3) as traders chase the stock stockanalysis.com. A financial commentary noted that Archer “has been capturing eyes on the market floor” with steady growth anchored around new technical milestones stockstotrade.com. Indeed, key ratios remain weak (negative profitability and returns), underscoring that Archer’s valuation
3 October 2025
·
Mercurity Fintech (MFH) Stock Explodes Amid Crypto & AI Bets – 1,000% Rally or Bubble?

Mercurity Fintech (MFH) Stock Explodes Amid Crypto & AI Bets – 1,000% Rally or Bubble?

Key Facts: Mercurity Fintech Holding Inc (NASDAQ: MFH) is a small-cap “next-gen fintech” company (market cap ~$1.3 B) focused on blockchain/digital assets, AI infrastructure, and financial services tipranks.com. In 2025 the stock has soared – roughly +1,320% year-to-date – hitting about $28 by Oct 3 tradingview.com. Its 52-week range is ~$1.03–$24.99; October 2025 trading has seen wild swings (e.g. +15.8% Oct 2 and -27.6% Oct 1) tradingview.com marketbeat.com. Key recent developments include a $200 M Solana venture line, blockchain asset-tokenization deals, and index inclusions; insiders tout it as a bridge between crypto and traditional finance stocktitan.net thepaypers.com. Analyst consensus is bearish: a “Hold” rating with only a
3 October 2025
··
USA Rare Earth (USAR) Stock Skyrockets on Major UK Acquisition and White House Talks

USA Rare Earth Stock Rockets on White House Rare-Earth Buzz – What You Need to Know

Stock Performance on Yahoo Finance USA Rare Earth trades on Nasdaq under ticker USAR. In the week leading up to Oct. 3, 2025, USAR’s stock price surged dramatically. For example, on Oct. 2 after-hours trading, shares jumped ~10% to about $24.93 seekingalpha.com, and by midday Oct. 3 they were around $26.00 (up ~15% on the day) stockanalysis.com. This was an all-time high for the stock, reflecting intense investor interest. (Year-to-date, USAR shares have roughly doubled energynews.oedigital.com.) The volume spiked as news broke of White House discussions and major company deals. Recent trading days (early Oct 2025) saw extreme volatility. News on Oct.
3 October 2025
·
1 … 1,150 1,151 1,152 1,153 1,154 … 1,177

Stock Market Today

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

Tower Semiconductor stock jumps again on Nvidia optics tie-up as earnings near

8 February 2026
Tower Semiconductor shares rose 7.7% to $139.04 Friday after announcing a collaboration with Nvidia on AI data-center networking. The stock touched $141 intraday and gained another 1% after hours. Investors await Tower’s Feb. 11 earnings for details on its silicon photonics work. No financial terms or shipment timeline were disclosed.
Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

Longsys Electronics stock heads into Monday after new guarantees; what 301308 investors watch next

8 February 2026
Longsys disclosed new guarantees for a 100 million yuan Hong Kong loan and a $9 million Brazil credit line, bringing its total approved guarantee quota to 11 billion yuan and outstanding guarantees to 5.81 billion yuan. The company said all guarantees are for consolidated subsidiaries and within approved limits. Shares closed at 288 yuan Friday, down 1.6%. China inflation and credit data are due this week.
MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

MACOM stock price steadies near highs into Monday after earnings pop and fresh filings

8 February 2026
MACOM shares rose 3.5% to $235.87 Friday after the company reported fiscal Q1 revenue of $271.6 million and raised its full-year data center growth outlook to 35–40%. Fidelity’s FMR LLC disclosed a 10.7% stake, while shareholder Susan Ocampo filed to potentially sell up to 100,000 shares. Stifel raised its price target to $255. MACOM expects to repay $161 million in convertible notes in March.
Go toTop